MicroRNA, Proteins, and Metabolites as Novel Biomarkers for Prediabetes, Diabetes, and Related Complications
Type 2 diabetes mellitus (T2DM) is no more a lifestyle disease of developed countries. It has emerged as a major health problem worldwide including developing countries. However, how diabetes could be detected at an early stage (prediabetes) to prevent the progression of disease is still unclear. Cu...
Main Authors: | Suniti Vaishya, Rucha D. Sarwade, Vasudevan Seshadri |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00180/full |
Similar Items
-
The Role of Circulating MicroRNA-126 (miR-126): A Novel Biomarker for Screening Prediabetes and Newly Diagnosed Type 2 Diabetes Mellitus
by: Yang Liu, et al.
Published: (2014-06-01) -
Occupational exposure to volatile organic compounds affects microRNA profiling: Towards the identification of novel biomarkers
by: Renata Sisto, et al.
Published: (2020-01-01) -
Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis
by: Sungjin Park, et al.
Published: (2018-04-01) -
Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
by: Ari Meerson, et al.
Published: (2019-04-01) -
MicroRNAs-1299, -126-3p and -30e-3p as Potential Diagnostic Biomarkers for Prediabetes
by: Cecil J. Weale, et al.
Published: (2021-05-01)